Short Interest in Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Drops By 89.4%

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the recipient of a large decrease in short interest in August. As of August 14th, there was short interest totaling 19 shares, a decrease of 89.4% from the July 30th total of 180 shares. Based on an average daily volume of 4,928 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CZMWY. UBS Group downgraded shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. Zacks Research lowered Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce”.

Carl Zeiss Meditec Stock Down 1.0%

Shares of CZMWY stock traded down $0.36 on Tuesday, hitting $37.33. 1,813 shares of the stock were exchanged, compared to its average volume of 4,367. The firm’s 50 day moving average is $33.47 and its two-hundred day moving average is $31.30. Carl Zeiss Meditec has a one year low of $26.65 and a one year high of $55.94.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.